Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2849]

Study reveals how high blood pressure increases susceptibility to heart damage caused by a key cancer treatment

Study reveals how high blood pressure increases susceptibility to heart damage caused by a key cancer treatment

A bacterial toxin can counteract colorectal cancer growth

A bacterial toxin can counteract colorectal cancer growth

Study: ADRIATIC clinical trial results suggest durvalumab may offer a new path in small cell lung cancer care

Study: ADRIATIC clinical trial results suggest durvalumab may offer a new path in small cell lung cancer care

Researchers discover that cholesterol-lowering drug can overcome chemotherapy resistance in triple-negative breast cancer

Researchers discover that cholesterol-lowering drug can overcome chemotherapy resistance in triple-negative breast...

ASCO GI 2026: Combining encorafenib and cetuximab with FOLFIRI may be effective first-line treatment for advanced CRC

ASCO GI 2026: Combining encorafenib and cetuximab with FOLFIRI may be effective first-line treatment for advanced...

Mathematicians tame cellular “noise” to control life at the single-cell level

Mathematicians tame cellular “noise” to control life at the single-cell level

Anti-diabetic drugs and their surprising impact on cancer progression

Anti-diabetic drugs and their surprising impact on cancer progression

Promising target improves antitumour response in preclinical models of pancreatic cancer

Promising target improves antitumour response in preclinical models of pancreatic cancer

FDA approves fam-trastuzumab deruxtecan-nxki with pertuzumab for unresectable or metastatic HER2-positive breast cancer

FDA approves fam-trastuzumab deruxtecan-nxki with pertuzumab for unresectable or metastatic HER2-positive breast...

$European Commission approves tafasitamab for the treatment of relapsed or refractory follicular lymphoma$

European Commission approves tafasitamab for the treatment of relapsed or refractory follicular lymphoma

More from ecancer